VPSense
Quantum Doppler Sensor for Early Stroke Detection
Company Overview
Snapshot
Founded in December 2024 by Idan Levy, VPSense operates with 1–10 employees. The company is currently in the Pre-Funding stage and holds one patent, indicating early-stage innovation in its field.
Business overview
VPSense is a Health Tech & Life Sciences company focused on developing quantum-based medical sensing technology for accelerated stroke diagnosis and intervention. Its core product analyzes Doppler signals to detect blood clots, providing rapid insights for emergency care and long-term stroke management. The technology aims to reduce treatment delays, mitigate complication risks, and improve patient outcomes within the healthcare industry, specifically targeting patients and providers with its B2B business model.
Log in to access full profile ›Company Intelligence Q&A
- What is VPSense's primary focus?
- VPSense develops quantum-based medical sensing technology to accelerate stroke diagnosis and intervention, aiming to improve patient outcomes.
- When was VPSense founded?
- VPSense was founded in December 2024.
- Who is the founder of VPSense?
- Idan Levy is the CEO and founder of VPSense.
- What technology does VPSense utilize?
- VPSense utilizes quantum Doppler sensor technology to analyze signals for detecting blood clots.
- What is VPSense's business model?
- VPSense operates with a B2B business model, targeting healthcare providers and patients.